American Healthcare REIT, Inc. (AHR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 900M 1.8B 2.7B Q3 '21: 1.1B Q4 '21: 419.9M Q1 '22: 701M Q2 '22: 990.1M Q3 '22: 1.3B Q4 '22: 1.4B Q1 '23: 1.5B Q2 '23: 1.6B Q3 '23: 1.7B Q4 '23: 1.7B Q1 '24: 1.8B Q2 '24: 1.9B Q3 '24: 2B Q4 '24: 2.1B Q1 '25: 2.1B Q2 '25: 2.1B Q3 '25: 2.2B Q4 '25: 2.3B Q1 '26: 2.4B Q2 '26: 2.5B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-200M 0 200M 400M 600M Q2 '17: -2.8M Q4 '21: 213.3M Q1 '22: 248.9M Q2 '22: 277M Q3 '22: 298.3M Q4 '22: 302M Q1 '23: 295.2M Q2 '23: 298M Q3 '23: 299.2M Q4 '23: 306.8M Q1 '24: 322.1M Q2 '24: 330.4M Q3 '24: 348.9M Q4 '24: 363.5M Q1 '25: 375.9M Q2 '25: 390.4M Q3 '25: 402.7M Q4 '25: 415.2M Q1 '26: 446.1M Q2 '26: 480.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-150M -100M -50M 0 50M 100M 150M Q3 '21: -9M Q4 '21: -47.8M Q1 '22: -38.9M Q2 '22: -48.5M Q3 '22: -56.8M Q4 '22: -81.3M Q1 '23: -104.2M Q2 '23: -99.1M Q3 '23: -91.6M Q4 '23: -71.5M Q1 '24: -49.5M Q2 '24: -35.3M Q3 '24: -33.5M Q4 '24: -37.8M Q1 '25: -40.7M Q2 '25: -32.8M Q3 '25: 27.3M Q4 '25: 69.8M Q1 '26: 100.3M Q2 '26: 121M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 700M 1.4B 2.1B Q3 '21: 1.7B Q4 '21: 1B Q1 '22: 1.1B Q2 '22: 1.1B Q3 '22: 1.2B Q4 '22: 1.3B Q1 '23: 1.4B Q2 '23: 1.4B Q3 '23: 1.5B Q4 '23: 1.5B Q1 '24: 1.5B Q2 '24: 1.6B Q3 '24: 1.6B Q4 '24: 1.7B Q1 '25: 1.7B Q2 '25: 1.7B Q3 '25: 1.7B Q4 '25: 1.8B Q1 '26: 1.9B Q2 '26: 2B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 150M 300M 450M Q3 '21: 187.7M Q4 '21: 17.9M Q1 '22: 45.5M Q2 '22: 70.5M Q3 '22: 132.8M Q4 '22: 147.8M Q1 '23: 149.3M Q2 '23: 135.3M Q3 '23: 107.1M Q4 '23: 98.5M Q1 '24: 68.7M Q2 '24: 108.3M Q3 '24: 142.3M Q4 '24: 176.1M Q1 '25: 242.7M Q2 '25: 254.7M Q3 '25: 298.8M Q4 '25: 294.4M Q1 '26: 314.9M Q2 '26: 362M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 80M 160M 240M Q4 '19: 111M Q1 '20: 113.4M Q2 '20: 110.5M Q3 '20: 108.1M Q4 '20: 210.8M Q1 '21: 197.5M Q2 '21: 197.7M Q3 '21: 181.8M Q4 '19 Q1 '20 Q2 '20 Q3 '20 Q4 '20 Q1 '21 Q2 '21 Q3 '21

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q1 '21: 179.6M Q2 '21: 179.6M Q3 '21: 179.6M Q1 '22: 65.6M Q2 '22: 65.8M Q3 '22: 65.8M Q1 '23: 66M Q2 '23: 66M Q3 '23: 66M Q1 '24: 104.3M Q2 '24: 130.7M Q3 '24: 133.7M Q1 '25: 156.9M Q2 '25: 161.1M Q3 '25: 169.8M Q1 '26: 188M Q2 '26: 193.3M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.80 -1.20 -0.60 0.00 0.60 1.20 1.80 Q3 '21: -0.19 Q4 '21: -0.95 Q1 '22: -0.93 Q2 '22: -1.15 Q3 '22: -1.33 Q4 '22: -1.25 Q1 '23: -1.59 Q2 '23: -1.52 Q3 '23: -1.40 Q4 '23: -1.08 Q1 '24: -0.73 Q2 '24: -0.53 Q3 '24: -0.47 Q4 '24: -0.30 Q1 '25: -0.30 Q2 '25: -0.25 Q3 '25: 0.11 Q4 '25: 0.41 Q1 '26: 0.58 Q2 '26: 0.68 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.